SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-084082
Filing Date
2024-04-02
Accepted
2024-04-02 07:31:17
Documents
19
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d661667ddef14a.htm   iXBRL DEF 14A 439113
6 GRAPHIC g661667g02n01.jpg GRAPHIC 33645
7 GRAPHIC g661667g02n02.jpg GRAPHIC 23869
8 GRAPHIC g661667g03g03.jpg GRAPHIC 22608
9 GRAPHIC g661667g34g34.jpg GRAPHIC 103480
10 GRAPHIC g661667snap1.jpg GRAPHIC 3244
  Complete submission text file 0001193125-24-084082.txt   1308874

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA xoma-20231231.xsd EX-101.SCH 4799
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20231231_def.xml EX-101.DEF 4478
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20231231_lab.xml EX-101.LAB 6356
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20231231_pre.xml EX-101.PRE 3790
22 EXTRACTED XBRL INSTANCE DOCUMENT d661667ddef14a_htm.xml XML 76216
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39801 | Film No.: 24812224
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)